These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33979097)

  • 1. E-cadherin and N-cadherin Immunohistochemical Expression in Proliferating Urothelial Lesions: Potential Novel Cancer Predictive EMT Profiles.
    Shash LS; Ibrahim RA; Elgohary SA
    Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):657-666. PubMed ID: 33979097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.
    Singh R; Singh UP; Agrawal V; Garg M
    Mol Biol Rep; 2022 Aug; 49(8):7541-7556. PubMed ID: 35593896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
    Martins-Lima C; Miranda-Gonçalves V; Lobo J; Constâncio V; Leite-Silva P; Guimarães-Teixeira C; Monteiro-Reis S; Sequeira JP; Cantante M; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    Cell Oncol (Dordr); 2022 Feb; 45(1):135-149. PubMed ID: 35064910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of miRNA-200c expression and epithelial-to-mesenchymal transition-related transcription factors in the primary bladder urothelial carcinoma.
    Narwal A; Kumari K; Kaushal S; Seth A; Nayak B; Rustagi Y; Dinda AK
    Urol Ann; 2023; 15(1):35-42. PubMed ID: 37006208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines.
    Zhang X; Liu G; Kang Y; Dong Z; Qian Q; Ma X
    PLoS One; 2013; 8(3):e57692. PubMed ID: 23520479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
    DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
    PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expressions of EMT markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.
    Tripathi K; Maurya N; Goel A; Singhai A; Garg M
    Mol Cell Biochem; 2023 Jun; 478(6):1169-1190. PubMed ID: 36239855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas.
    Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE
    Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.
    Hensley PJ; Zetter D; Horbinski CM; Strup SE; Kyprianou N
    Hum Pathol; 2016 Nov; 57():68-77. PubMed ID: 27402302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
    Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of N-Cadherin Expression in Tumor Transplants Produced From As+3- and Cd+2-Transformed Human Urothelial (UROtsa) Cell Lines.
    Sandquist EJ; Somji S; Dunlevy JR; Garrett SH; Zhou XD; Slusser-Nore A; Sens DA
    PLoS One; 2016; 11(5):e0156310. PubMed ID: 27224422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.
    Paliwal P; Arora D; Mishra AK
    Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
    Liu B; Miyake H; Nishikawa M; Fujisawa M
    Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
    Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
    Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
    Otto W; Breyer J; Herdegen S; Eder F; Bertz S; May M; Mayr R; Lausenmeyer EM; Denzinger S; van Rhijn BW; Burger M; Hartmann A
    Int Urol Nephrol; 2017 Mar; 49(3):431-437. PubMed ID: 28035618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cadherin switch assessment in the epithelial-mesenchymal transition of urothelial bladder carcinomas.
    Drocaş AI; Tomescu PI; Mitroi G; Drăgoescu PO; Mărgăritescu C; Stepan AE; Şurlin V; CrăiŢoiu Ş; Drocaş I; Ungureanu AM; Găman AE; Turculeanu A; Simionescu CE
    Rom J Morphol Embryol; 2016; 57(3):1037-1044. PubMed ID: 28002521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
    Breyer J; Gierth M; Shalekenov S; Aziz A; Schäfer J; Burger M; Denzinger S; Hofstädter F; Giedl C; Otto W
    World J Urol; 2016 May; 34(5):709-16. PubMed ID: 26394624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.